The following is a listing of recent U.S. Food and drug Administration updates and activities:

• FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)

• Baxter Hillrom Recalls WatchCare Incontinence Management System (IMS) for Risk of RF Interference with Nearby Medical Equipment

…

Sign Up for Free Trial

---

• Back
• MCN Blog